140 related articles for article (PubMed ID: 17301547)
1. [Why multi-national clinical trials now?--Industry perspective].
Miki S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):293-6. PubMed ID: 17301547
[TBL] [Abstract][Full Text] [Related]
2. [Operational aspect of participation in the multi-national clinical trials from the foreign pharmaceutical company's standpoint].
Namazu K
Gan To Kagaku Ryoho; 2007 Feb; 34(2):328-30. PubMed ID: 17301556
[TBL] [Abstract][Full Text] [Related]
3. [Participation in the international multi-countries study-operational issues from company view point].
Hada S
Gan To Kagaku Ryoho; 2007 Feb; 34(2):324-7. PubMed ID: 17301555
[TBL] [Abstract][Full Text] [Related]
4. [Participation to international registration trials--from the investigator's standpoint].
Ohtsu A
Gan To Kagaku Ryoho; 2007 Feb; 34(2):297-300. PubMed ID: 17301548
[TBL] [Abstract][Full Text] [Related]
5. [Impact of rapid advancement of international standardization on technical requirements for new drug registration].
Kurokawa T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):509-16. PubMed ID: 8678507
[TBL] [Abstract][Full Text] [Related]
6. [How to plan and execute multinational clinical studies properly-management of ethnic differences, private information, and genetic testing].
Iwasaki M
Gan To Kagaku Ryoho; 2010 May; 37(5):771-6. PubMed ID: 20495304
[TBL] [Abstract][Full Text] [Related]
7. [Globalization of clinical trials].
Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
[TBL] [Abstract][Full Text] [Related]
8. Challenges in the clinical development requirements for the marketing authorization of new medicines in southeast Asia.
Kudrin A
J Clin Pharmacol; 2009 Mar; 49(3):268-80. PubMed ID: 19168433
[TBL] [Abstract][Full Text] [Related]
9. Current status of phase I clinical trials in Asia: an academic perspectives.
Louisa M; Takeuchi M; Setiabudy R; Nafrialdi ; Takeuchi M
Acta Med Indones; 2012 Jan; 44(1):71-7. PubMed ID: 22451190
[TBL] [Abstract][Full Text] [Related]
10. Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes?
van Niekerk C; Ginsberg A
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1367-72. PubMed ID: 19861008
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials and approval of anti-cancer agents.
Iwasaki M; Hinotsu S; Katsura J
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i65-69. PubMed ID: 20870922
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials registries: towards improved access to therapeutic data.
Prescrire Int; 2008 Dec; 17(98):256-9. PubMed ID: 19425275
[TBL] [Abstract][Full Text] [Related]
13. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials registration efforts gain some ground.
Zielinski SL
J Natl Cancer Inst; 2005 Mar; 97(6):410-1. PubMed ID: 15769999
[No Abstract] [Full Text] [Related]
15. Establishing consistency across all regions in a multi-regional clinical trial.
Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF
Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851
[TBL] [Abstract][Full Text] [Related]
16. Is ICH exportable outside the European Union?
Dent NJ
Qual Assur; 2000; 8(1):19-31. PubMed ID: 11710304
[TBL] [Abstract][Full Text] [Related]
17. [The role of the Japan Clinical Oncology Group].
Ohe Y; Saijo N
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1127-32. PubMed ID: 10945006
[TBL] [Abstract][Full Text] [Related]
18. A comparative method of evaluating quality of international clinical studies in China: Analysis of site visit reports of the Clinical Research Operations and Monitoring Center.
Chang JJ; Xu J; Fan D
Contemp Clin Trials; 2008 Sep; 29(5):654-62. PubMed ID: 18450522
[TBL] [Abstract][Full Text] [Related]
19. [Participation in the global study. Activities and issues from the bedside].
Yamamoto N
Gan To Kagaku Ryoho; 2007 Feb; 34(2):316-9. PubMed ID: 17301553
[TBL] [Abstract][Full Text] [Related]
20. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
Andoh M; Fujiwara Y; Shimada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
